TALEN

TALEN1-greb1

ID
ZDB-TALEN-170928-1
Name
TALEN1-greb1
Previous Names
None
Target
Target Sequence 1
5' - TATACAGGACACCTT - 3'
Target Sequence 2
5' - TGTGCAACACTTCCT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf1050 greb1
Expression
Gene expression in Wild Types + TALEN1-greb1
No data available
Phenotype
Phenotype resulting from TALEN1-greb1
No data available
Phenotype of all Fish created by or utilizing TALEN1-greb1
Phenotype Fish Conditions Figures
neural plate increased width, abnormal greb1zf1050/zf1050 standard conditions Fig. 6 with image from Li et al., 2017
axial chorda mesoderm position, abnormal greb1zf1050/zf1050 standard conditions Fig. 6 with image from Li et al., 2017
hypophysis lhb expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
hypophysis prl expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
whole organism prl expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 9 from Li et al., 2017
embryo development delayed, abnormal greb1zf1050/zf1050 standard conditions Fig. 5 with image from Li et al., 2017
blood plasma Luteinizing hormone decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
whole organism decreased life span, abnormal greb1zf1050/zf1050 standard conditions Fig. 5 with imageFig. 7 with image from Li et al., 2017
prechordal plate position, abnormal greb1zf1050/zf1050 standard conditions Fig. 6 with image from Li et al., 2017
somatotropin secreting cell decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 8 with image from Li et al., 2017
whole organism decreased length, abnormal greb1zf1050/zf1050 standard conditions Fig. 7 with image from Li et al., 2017
blood plasma growth hormone decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
whole organism malformed, abnormal greb1zf1050/zf1050 standard conditions Fig. 5 with image from Li et al., 2017
hypophysis pomca expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
whole organism gh1 expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 9 from Li et al., 2017
hypophysis tshba expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
prolactin secreting cell decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 8 with image from Li et al., 2017
whole organism tshba expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 9 from Li et al., 2017
hypophysis decreased size, abnormal greb1zf1050/zf1050 standard conditions Fig. 8 with image from Li et al., 2017
blood plasma Follicle stimulating hormone decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
hypophysis fshb expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
whole organism cga expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 9 from Li et al., 2017
hypophysis gh1 expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
follicle stimulating hormone secreting cell decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 8 with image from Li et al., 2017
blood plasma Prolactin decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
prechordal plate decreased length, abnormal greb1zf1050/zf1050 standard conditions Fig. 6 with image from Li et al., 2017
thyroid stimulating hormone secreting cell decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 8 with image from Li et al., 2017
convergent extension disrupted, abnormal greb1zf1050/zf1050 standard conditions Fig. 6 with image from Li et al., 2017
hypophysis cga expression decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
embryo development disrupted, abnormal greb1zf1050/zf1050 standard conditions Fig. 5 with image from Li et al., 2017
segmental plate increased width, abnormal greb1zf1050/zf1050 standard conditions Fig. 6 with image from Li et al., 2017
whole organism decreased weight, abnormal greb1zf1050/zf1050 standard conditions Fig. 7 with image from Li et al., 2017
whole organism dead, abnormal greb1zf1050/zf1050 standard conditions Fig. 7 with image from Li et al., 2017
blood plasma thyroid stimulating hormone decreased amount, abnormal greb1zf1050/zf1050 standard conditions Fig. 10 from Li et al., 2017
Citations